[ U.S. CDMRP – Neurotoxin Exposure Treatment Parkinson’s Program Investigator Initiated Research Award ]
Event details
| Date | 18.08.2020 |
| Category | Call for proposal |
Aim: Through the Congressionally Directed Medical Research Program (CDMRP), the Department of Defense is announcing the Neurotoxin Exposure Treatment Parkinson’s Program (NETP) Awards. The NETP Investigator Initiated Research Award supports highly rigorous, multidisciplinary, high-impact research projects that have the potential to make an important contribution to neurotoxin exposure and treatment-related Parkinson’s research. This award mechanism supports the full spectrum of research from basic science through clinical research. Preliminary data to support feasibility is encouraged but not required. The NETP Program seeks applications from investigators working in a broad spectrum of disciplines including, but not limited to, basic science, engineering, bioinformatics, population science, translational research, and clinical research.
To meet the intent of the award mechanism, applications must address one of the FY20 NETP Focus Areas, which are listed at the end of this announcement.
Funding: max. $1’200’000
Duration: 3 years
Eligibility: Applicants from international organizations or institutions are eligible to apply, and there are no citizenship restrictions. Investigators at or above the level of Assistant Professor (or equivalent) are eligible to be named as the Principal Investigator (PI) on the application. The NETP Program IIRA requires that the PI dedicate at least 15% of their full-time professional effort to this award during the award period.
How to Apply: Pre-applications are submitted through the eBRAP platform. They should contain contact information, a letter of intent, and a list of collaborators and key personnel as suggested on the platform. Full applications (by invitation) will be made via a Grants.gov workspace. Full application packages can be downloaded from Grants.gov at any time.
Pre-Application Deadline: 18-Aug-2020, 5:00 p.m. EST
Full Application Deadline: 16-Sep-2020, 11:59 p.m. EST
Grants.gov Funding Opportunity Number: W81XWH-20-NETP-IIRA
Further information
FY20 NETP Focus Areas
To meet the intent of the award mechanism, applications must address one of the FY20 NETP Focus Areas, which are listed at the end of this announcement.
Funding: max. $1’200’000
Duration: 3 years
Eligibility: Applicants from international organizations or institutions are eligible to apply, and there are no citizenship restrictions. Investigators at or above the level of Assistant Professor (or equivalent) are eligible to be named as the Principal Investigator (PI) on the application. The NETP Program IIRA requires that the PI dedicate at least 15% of their full-time professional effort to this award during the award period.
How to Apply: Pre-applications are submitted through the eBRAP platform. They should contain contact information, a letter of intent, and a list of collaborators and key personnel as suggested on the platform. Full applications (by invitation) will be made via a Grants.gov workspace. Full application packages can be downloaded from Grants.gov at any time.
Pre-Application Deadline: 18-Aug-2020, 5:00 p.m. EST
Full Application Deadline: 16-Sep-2020, 11:59 p.m. EST
Grants.gov Funding Opportunity Number: W81XWH-20-NETP-IIRA
Further information
- To see the program announcement, navigate to the search page on Grants.gov and search for the Opportunity Number W81XWH-20-NETP-IIRA
- For questions about the eBRAP or Grants.gov platforms, contact the Research Office.
FY20 NETP Focus Areas
- Quantifiable gene - environment interactions and the risk for or progression of Parkinson’s disease following neurotoxin exposure.
- Basic biology of non-motor symptoms that could lead to the development of new treatments for Parkinson’s disease following neurotoxin exposure.
- System-level mechanism of dopamine refractory motor symptoms in Parkinson’s disease, including postural instability, freezing of gait, and treatment-associated dystonia, that could lead to development of new treatments in patients with neurotoxin exposure.
- Clinical and research application of digital health technology leading to development of new treatments for Parkinson’s disease in those individuals exposed to neurotoxins.
Practical information
- General public
- Free